FINWIRES · TerminalLIVE
FINWIRES

Goldman Sachs Adjusts Gilead Sciences Price Target to $130 From $125, Maintains Neutral Rating

By

Gilead Sciences (GILD) has an average rating of overweight and mean price target of $161, according to analysts polled by FactSet.

Price: $138.52, Change: $-1.25, Percent Change: -0.89%

What else is happening in Wire?